Finance

Smiths Group Annual Results: Slower Sales Growth Puts Focus on Margins

Marcus SterlingPublished 28m ago3 min readBased on 9 sources
Reading level
Smiths Group Annual Results: Slower Sales Growth Puts Focus on Margins
source:smiths.com

Smiths Group published its annual results for the year to 31 July 2026 on 22 September 2026. The date was pre-flagged in its Q3 trading update and matches the London Stock Exchange calendar entry for SMIN on Sep 22, 2026. London Stock Exchange

For the 2026 financial year, the company guided to 3-4% organic revenue growth and a headline operating profit margin of around 20%. Smiths Group Investor Presentation Organic means sales growth without the effects of takeovers or currency moves. Margin is the share of sales kept as operating profit. That guidance carried through from the half-year results for the six months to 31 January 2026. Then management expected 3-4% organic growth for the full year, with second-half growth inside its 5-7% medium-term target range, and a margin of about 20%, on the way to 21-23% over time.

The 3-4% range was lower than the starting forecast. In September 2025, Smiths forecast 4%-6% organic revenue growth from continuing operations for the year to July 2026. Reuters The half-year update made the lower full-year range formal, while keeping the 5-7% medium-term reference for the second half.

The half year finished at the top of the revised range. Smiths reported 4.0% organic revenue growth for the six months to 31 January 2026, with an operating profit margin of 17.2%, up 50 basis points. A basis point is one-hundredth of a percentage point, so 50 is half a point. Return on capital employed, a measure of profit against money invested, was 18.4%, up 130 basis points. Headline earnings per share, or profit per share, grew 8.4%.

Reported sales got extra help from deals. Smiths said reported revenue in the third quarter of 2026 included a 2.1% benefit from acquisitions, while reported revenue for the first nine months included a 1.6% benefit. Smiths Q3 Trading Update Organic strips out takeovers and currency. Reported does not.

For comparison, the prior year was strong on paper. For the year to 31 July 2025, Smiths reported 8.9% organic revenue growth, above guidance that had been raised twice, with an operating margin of 17.4% at the top of its guided range. Smiths Group 2025 Annual Results Headline earnings per share grew 14.8%, headline operating profit margin rose 60 basis points, and headline operating cash conversion was 99%, up 2 percentage points. Cash conversion shows how much operating profit arrives as cash.

Shares fell 5.9% after the company trimmed its full-year outlook, leaving it the largest faller in the FTSE 100 at the time.

The broader context here is a change in emphasis. FY2025 combined high-single-digit organic growth with 60 basis points of margin expansion and near-total cash conversion. FY2026, on the guided figures, reverses that balance. Growth slows to 3-4%. The margin is asked to do more, rising from 17.2% in the first half toward about 20% for the full year and, over time, toward 21-23%. For savers and investors, that means less help from sales and more reliance on cost control and sales mix.

In my view, the two things to reconcile are timing and quality. A full-year margin of about 20% from a 17.2% first half implies a much stronger second half from operating leverage, mix or cost timing. That is possible in a project and aftermarket business with second-half weighting, but it puts more forecast risk on the second half. The parallel reference to 5-7% organic growth in the second half, against 3-4% for the full year and 4.0% in the first half, points the same way. The exit rate matters more than the average.

Looking at what this means for how the print will be read, cash conversion and return on capital are the cross-checks. The 99% headline operating cash conversion in FY2025 and 18.4% return on capital in the first half of 2026 set a high bar for capital discipline. If margin expansion comes with steady conversion and rising returns, the market will treat it as lasting. If it comes with a build in working capital or acquisition-led reported growth covering softer organic volumes, the 5.9% sell-off and FTSE 100 underperformance will look like positioning for that risk. The Q3 disclosure of a 2.1% acquisition benefit keeps that split in focus.